Example: Heart Attack

Search clinical trials for: Dimethyl Sulfoxide

Total 49 results

NCT04492306

Not yet recruiting

Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment

Conditions: Dental Diseases
NCT04439279

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma
NCT04439292

Active, not recruiting

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma
NCT04439318

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma
NCT04439357

Active, not recruiting

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Plasma Cell Myeloma
NCT04201457

Recruiting

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Conditions: Low Grade Glioma (LGG) of Brain With BRAF Aberration; High Grade Glioma (HGG) of the Brain With BRAF Aberration; Low Grade Glioma of Brain With Neurofibromatosis Type 1
NCT04118556

Not yet recruiting

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease (GvHD) After Allogenic Stem-cell Transplantation (HSCT)

Conditions: GVHD, Acute
NCT03939234

Recruiting

Peptide Vaccination With IO103 and IO120 in Patients With Chronic Lymphocytic Leukemia.

Conditions: Chronic Lymphocytic Leukemia
NCT03919071

Recruiting

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Conditions: Anaplastic Astrocytoma; Anaplastic Ganglioglioma; Anaplastic Pleomorphic Xanthoastrocytoma; Glioblastoma; Malignant Glioma; WHO Grade III Glioma
NCT03814343

Recruiting

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis

Conditions: Fungal Infection; Onychomycosis; Fungus, Nail
NCT03806309

Recruiting

Maintenance Therapy With OSE2101 Vaccine Alone or in Combination With Nivolumab, or FOLFIRI After Induction Therapy With FOLFIRINOX in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Conditions: Pancreatic Ductal Adenocarcinoma; Locally Advanced Cancer; Metastatic Cancer
NCT03794297

Recruiting

Dabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 Mutations

Conditions: Erdheim-Chester Disease
NCT03715985

Recruiting

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Conditions: Malignant Melanoma, Metastatic; Non Small Cell Lung Cancer Metastatic; Kidney Cancer Metastatic
NCT03716583

Recruiting

Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer

Conditions: Radiation Dermatitis; Radiation Dermatitis Acute; Breast Cancer
NCT03103594

Completed

Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A

Conditions: Bladder Pain Syndrome
NCT03004976

Active, not recruiting

Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke

Conditions: Stroke; Stroke, Acute; Brain Injury, Acute
NCT02701257

Terminated

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

Conditions: Diabetes Mellitus Type 1
NCT02452099

Completed

Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.

Conditions: Multiple Myeloma; Lymphomas; Leukemias
NCT02337192

Completed

Antimicrobial Photodynamic Therapy Applied in Orthodontic. Orthodontic Patients.

Conditions: Dentist-Patient Relations
NCT02281760

Completed

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

Conditions: BRAF V600E Mutation
NCT02239393

Completed

Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study

Conditions: Multiple Sclerosis
NCT02224781

Recruiting

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Conditions: Metastatic Melanoma; Recurrent Melanoma; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Unresectable Cutaneous Melanoma
NCT02206477

Unknown status

DMSO for Prevention of Capsular Contraction in Alloplastic Breast Reconstruction

Conditions: Breast Capsular Contracture; Dimethyl Sulfoxide
NCT02196181

Active, not recruiting

Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery

Conditions: Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Unresectable Melanoma
NCT02181478

Active, not recruiting

Intra-Osseous Co-Transplant of UCB and hMSC

Conditions: Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Myelofibrosis; Relapsed Non-Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Lymphoid Malignancies; Chronic Myelogenous Leukemia
NCT02148393

Completed

Implantation Enhancement by Elective Cryopreservation of All Viable Embryos

Conditions: Infertility; OHSS
NCT02101788

Active, not recruiting

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Conditions: Micropapillary Serous Carcinoma; Ovarian Serous Adenocarcinoma; Primary Peritoneal Serous Adenocarcinoma; Recurrent Low Grade Ovarian Serous Adenocarcinoma; Recurrent Primary Peritoneal Serous Adenocarcinoma
NCT02078284

Completed

Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

Conditions: Thrombocytopenia
NCT02032134

Terminated

Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia

Conditions: Thrombocytopenia; Primary Thrombocytopenia,Unspecified; Thrombocytopenia Chemotherapy Induced
NCT01980940

Completed

The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

Conditions: Osteoarthritis Pain
NCT01971385

Completed

Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis

Conditions: Herpes Labialis
NCT01725100

Completed

A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies

Conditions: Cancer
NCT01639885

Completed

Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer

Conditions: Recurrent Ovarian Cancer
NCT01525017

Completed

A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer

Conditions: Metastatic Renal Cell Carcinoma
NCT01459393

Completed

Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment

Conditions: Actinic Keratosis
NCT01456065

Unknown status

Safety of Active Immunotherapy in Subjects With Ovarian Cancer

Conditions: Ovarian Epithelial Cancer
NCT01123915

Terminated

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

Conditions: HIV Infections
NCT01106417

Completed

Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion

Conditions: Cervical Degenerative Disc Disease; Degenerative Spondylolisthesis; Spinal Stenosis
NCT01074567

Unknown status

DMSO Efficacy in IC/PBS Patients During and After Treatment

Conditions: Cystitis, Interstitial
NCT01069263

Unknown status

Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis

Conditions: Interstitial Cystitis
NCT00676507

Completed

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Conditions: Lung Neoplasm; Carcinoma Non-small Cell Lung Cancer Stage IIIA; Carcinoma Non-small Cell Lung Cancer Stage IIIB; Carcinoma Non-small Cell Lung Cancer Stage IV
NCT00667095

Terminated

Over Active Bladder Instillation Study - Botox

Conditions: Overactive Bladder; Urinary Urge Incontinence; Urinary Incontinence; Detrusor Hyperreflexia; Urge Incontinence
NCT00631787

Completed

Evaluation of Toxicity From Stem Cell Transplant

Conditions: Organ Dysfunction; Hemolysis
NCT00583219

Completed

Botulin-A Toxin Instillations and Overactive Bladder

Conditions: Overactive Bladder; Detrusor Instability; Detrusor Hyperreflexia
NCT00471393

Completed

Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease

Conditions: Temporomandibular Degenerative Joint Disease
NCT00317070

Terminated

Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)

Conditions: Interstitial Cystitis; Bladder Diseases
NCT00294112

Completed

Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease

Conditions: Crohn's Disease
NCT00218829

Completed

DMSO-PDT of BCC - A 6 Year Follow up

Conditions: Carcinoma, Basal Cell
NCT00118313

Completed

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Conditions: Melanoma (Skin)